MercoPress, en Español
Get our news on your inbox! Suscribe x
Montevideo, September 22nd 2018 - 21:01 UTC
Shares in German pharmaceutical group Bayer have dropped sharply following a US verdict linking a product to cancer. By mid-morning on Monday, Bayer's shares had lost 10.4% of their value.
Get our news on your inbox!